Celastrol (6) and DS were linked via the MMP-2-responsive peptide PVGLIG to achieve specific drug release through hydrolysis of the linker by MMP-2 enzyme overexpressed in inflamed joints of RA patients [78]. This evidence concerns the gene MMP2 and rheumatoid arthritis.